Sleep Breath 2004; 8(4): 209-212
DOI: 10.1055/s-2004-860898

Copyright © 2004 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

The Ineffectiveness of Magnotherapy in a Patient with Obstructive Sleep Apnea Syndrome and Cardiovascular Comorbidity

Yaron Dagan1 , Katy Borodkin1
  • 1Institute for Fatigue and Sleep Medicine, “Sheba” Medical Center, Tel Hashomer, Israel
Further Information

Publication History

Publication Date:
20 December 2004 (online)


Obstructive sleep apnea syndrome (OSAS) is associated with mild to severe cardiovascular risks. The most common standard treatment for OSAS, continuous positive airway pressure, was found to have beneficial effects on cardiovascular sequelae of OSAS. Additionally, commercial companies promote nonprescription treatments for OSAS. These products frequently lack scientific support for their efficacy and need further research. We report an objective test of magnetic therapy, one such product, in a patient with OSAS and cardiovascular comorbidities. Two nights of polysomnographic recording using the split-night protocol did not reveal any consistent differences in OSAS symptoms whether the patient slept with or without the magnetic equipment. It was concluded that magnetic treatment was unsuccessful in reducing OSAS symptoms in our patient and may even increase possible cardiovascular and stroke risks by preventing the patient from pursuing an adequate medical treatment, such as continuous positive airway pressure.


  • 1 Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults.  N Engl J Med. 1993;  328 1230-1235
  • 2 Peker Y, Hedner J, Norum J, Kraiczi H, Carlson J. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea. A 7-year follow-up.  Am J Respir Crit Care Med. 2002;  166 159-165
  • 3 Meoli A L, Rosen C L, Kristo D et al.. Nonprescription treatments of snoring or obstructive sleep apnea: an evaluation of products with limited scientific evidence.  Sleep. 2003;  26 619-624
  • 4 Edinger J D, Fins A I, Glenn D M et al.. Insomnia and the eye of the beholder: are there clinical markers of objective sleep disturbances among adults with and without insomnia complaints?.  J Consult Clin Psychol. 2000;  68 586-593
  • 5 Bixler E O, Vgontzas A N, Lin H -M et al.. Association of hypertension and sleep-disordered breathing.  Arch Intern Med. 2000;  160 2289-2295
  • 6 Nieto F J, Young T B, Lind B K et al.. Association of sleep-disordered breathing, sleep-apnea, and hypertension in a large community-based study.  JAMA. 2000;  283 1829-1836
  • 7 Ohayon M M, Guilleminault C, Priest R G, Zulley J, Smirne S. Is sleep-disordered breathing an independent risk factor for hypertension in the general population (13,057 subjects)?.  J Psychosom Res. 2000;  48 593-601
  • 8 Mooe T, Franklin K A, Holmstrom K, Rabben T, Wiklund U. Sleep-disordered breathing and coronary artery disease. Long-term prognosis.  Am J Respir Crit Care Med. 2001;  164 1910-1913
  • 9 Mohsenin V. Sleep-related breathing disorders and risk of stroke.  Stroke. 2001;  32 1271-1278
  • 10 Neau J -P, Paquereau J, Meurice J -C, Chavagnat J -J, Gil R. Stroke and sleep apnoea: cause or consequence?.  Sleep Med Rev. 2002;  6 457-469
  • 11 Akashiba T, Minemura H, Yamamoto H, Kosaka N, Saito O, Horie T. Nasal continuous positive airway pressure changes blood pressure “non-dippers” to “dippers” in patients with obstructive sleep apnea.  Sleep. 1999;  22 849-853
  • 12 Becker H F, Jerrentrup A, Ploch T et al.. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea.  Circulation. 2003;  107 68-73
  • 13 Suzuki M, Otsuka K, Guilleminault C. Long-term nasal continuous positive airway pressure administration can normalize hypertension in obstructive sleep apnea patients.  Sleep. 1993;  16 545-549
  • 14 Pepperell J C, Ramdassingh-Dow S, Crosthwaite N et al.. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomized parallel trial.  Lancet. 2002;  359 204-210
  • 15 Engleman H M, Gough K, Martin S E, Kingshott R N, Padfield P L, Douglas N J. Ambulatory blood pressure on and off continuous positive airway pressure therapy for the sleep apnea/hypopnea syndrome: effects in “non-dippers”.  Sleep. 1996;  19 378-381
  • 16 Narciewicz K, Kato M, Phillips B G, Pesek C, Davison D E, Somers V K. Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea.  Circulation. 1999;  100 2332-2335
  • 17 Dexter D. Magnetic therapy is ineffective for the treatment of snoring and obstructive sleep apnea syndrome.  Wis Med J. 1997;  96 35-37

Katy Borodkin M.A. 

Institute for Fatigue and Sleep Medicine, “Sheba”

Medical Center, Tel Hashomer

52621, Israel